• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Cannabis Investment Firm Acquires Publicly Traded COBI to Create Marijuana Penny Stock Company BANGI

Share:

November 25, 2018

Bangi Investments, LLC has acquired publicly traded company Compass Biotechnologies, Inc. to gain greater access to public markets and to continue expanding its success in the cannabis marketspace. The company will go by the name BANGI, which is a noun in the African dialect Swahili meaning “marijuana” or “hemp”.

“Real Estate is agnostic to the cannabis industry; every sector from cultivation to extracting and retail relies heavily upon it. I’m excited about the prospects in store for BANGI, and I will be instrumental in this transition over the next 90 days,” said Rick Shykora, CEO of Compass Biotechnologies, Inc.

BANGI, a diversified investment vehicle that acquires and leases specialized real estate assets, understands the integral role that real estate plays in the $30 billion cannabis industry and plans to further its reach with the acquisition of COBI. BANGI will trade as OTC: COBI until approval for its unique ticker symbol. To learn more visit www.bangistock.com.

Date: November 26, 2018

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: Cision

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Anlon Healthcare Acquires Bizotic Lifescience LimitedAnlon Healthcare Acquires Bizotic Lifescience Limited
  • Applied UV Announces Acquisition of the Airocide(R) Technology Platform for Airborne Pathogen ReductionApplied UV Announces Acquisition of the Airocide(R) Technology Platform for Airborne Pathogen Reduction
  • Dexcom Sees Revenue Growth in Q2 2020 Despite COVID-19 UncertaintiesDexcom Sees Revenue Growth in Q2 2020 Despite COVID-19 Uncertainties
  • ApolloMD Partners with Cedar to Implement Optimized Online Patient Billing ExperienceApolloMD Partners with Cedar to Implement Optimized Online Patient Billing Experience
  • Sony Unveils Wearable for Secure Mobile Health & Remote MonitoringSony Unveils Wearable for Secure Mobile Health & Remote Monitoring
  • Aya Healthcare Acquires Winnow AI to Bolster Physician RecruitmentAya Healthcare Acquires Winnow AI to Bolster Physician Recruitment
  • AI2ET Framework Revolutionizes Healthcare AI RegulationAI2ET Framework Revolutionizes Healthcare AI Regulation
  • Seeman Holtz Property & Casualty Acquires Premier Medical Practice GroupSeeman Holtz Property & Casualty Acquires Premier Medical Practice Group

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications